A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide

Clinical trial NCT00135408 · COMPLETED

Trial details

NCT number: NCT00135408
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2005-12-01
Primary completion: 2007-07-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.